Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1868 1
1956 2
1969 1
1973 1
1975 4
1977 4
1978 2
1979 4
1980 6
1981 5
1982 7
1983 4
1984 6
1985 14
1986 10
1987 11
1988 12
1989 11
1990 9
1991 12
1992 10
1993 9
1994 24
1995 17
1996 13
1997 13
1998 4
1999 18
2000 22
2001 28
2002 23
2003 21
2004 18
2005 27
2006 15
2007 31
2008 14
2009 14
2010 15
2011 11
2012 7
2013 9
2014 9
2015 10
2016 11
2017 14
2018 14
2019 20
2020 16
2021 15
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

587 results
Results by year
Filters applied: . Clear all
Page 1
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.
Usmani SZ, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Rosinol L, Chari A, Bhutani M, Karlin L, Benboubker L, Pei L, Verona R, Girgis S, Stephenson T, Elsayed Y, Infante J, Goldberg JD, Banerjee A, Mateos MV, Krishnan A. Usmani SZ, et al. Among authors: stephenson t. Lancet. 2021 Aug 21;398(10301):665-674. doi: 10.1016/S0140-6736(21)01338-6. Epub 2021 Aug 10. Lancet. 2021. PMID: 34388396 Clinical Trial.
Teclistamab in Relapsed or Refractory Multiple Myeloma.
Moreau P, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Nooka AK, Martin T, Rosinol L, Chari A, Karlin L, Benboubker L, Mateos MV, Bahlis N, Popat R, Besemer B, Martínez-López J, Sidana S, Delforge M, Pei L, Trancucci D, Verona R, Girgis S, Lin SXW, Olyslager Y, Jaffe M, Uhlar C, Stephenson T, Van Rampelbergh R, Banerjee A, Goldberg JD, Kobos R, Krishnan A, Usmani SZ. Moreau P, et al. Among authors: stephenson t. N Engl J Med. 2022 Aug 11;387(6):495-505. doi: 10.1056/NEJMoa2203478. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35661166 Clinical Trial.
Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, Simmons R, Zavala M, O'Mahoney L, Chalder T, Crawley E, Ford TJ, Harnden A, Heyman I, Swann O, Whittaker E; CLoCk Consortium, Ladhani SN. Stephenson T, et al. Lancet Child Adolesc Health. 2022 Apr;6(4):230-239. doi: 10.1016/S2352-4642(22)00022-0. Epub 2022 Feb 8. Lancet Child Adolesc Health. 2022. PMID: 35143770 Free PMC article.
Prevention and Therapeutic Innovation in the Management of Child Health.
Hoey H, Stephenson T, Namazova-Baranova L, Pettoello-Mantovani M, Mestrovic J, Vural M, Crushell E. Hoey H, et al. Among authors: stephenson t. J Pediatr. 2019 May;208:300-301. doi: 10.1016/j.jpeds.2019.01.056. J Pediatr. 2019. PMID: 31027629 No abstract available.
Post-conviction polygraph testing of sex offenders.
Grubin D, Kamenskov M, Dwyer RG, Stephenson T. Grubin D, et al. Among authors: stephenson t. Int Rev Psychiatry. 2019 Mar;31(2):141-148. doi: 10.1080/09540261.2018.1561428. Epub 2019 Mar 27. Int Rev Psychiatry. 2019. PMID: 30915870
Broadening the migratory portfolio of altitudinal migrants.
Denryter K, Stephenson TR, Monteith KL. Denryter K, et al. Among authors: stephenson tr. Ecology. 2021 Aug;102(8):e03321. doi: 10.1002/ecy.3321. Epub 2021 Apr 30. Ecology. 2021. PMID: 33690892 Free PMC article. No abstract available.
Continuously advancing quality care.
Molloy A, Stephenson T, Marshall M. Molloy A, et al. Among authors: stephenson t. Arch Dis Child. 2022 Feb;107(2):107-108. doi: 10.1136/archdischild-2020-321394. Epub 2021 Jan 17. Arch Dis Child. 2022. PMID: 33455905 No abstract available.
587 results